Stanford University
Showing 25,801-25,820 of 36,308 Results
-
Mona Ranade
Clinical Associate Professor, Radiology
BioMona Ranade, MD is a radiologist specializing in Vascular & Interventional Radiology and is currently a Clinical Associate Professor of Radiology at Stanford University. She is a board-certified interventional radiologist with a clinical and academic focus on venous thromboembolism (DVT and PE), peripheral arterial disease, superficial venous disease, and women’s interventional health.
She completed her residency in Diagnostic Radiology at the Medical College of Wisconsin (2012–2016) and a fellowship in Vascular & Interventional Radiology at Mount Sinai Hospital in New York (2016–2017). She began her career in academic medicine at the Mount Sinai Health System, where she practiced from 2017 to 2020, followed by five years on faculty at UCLA Health (2020–2025) prior to joining Stanford.
Dr. Ranade is recognized as a thought leader in the treatment of deep vein thrombosis and pulmonary embolism, with extensive experience in managing complex venous disease. She has participated in several clinical trials in this space and currently serves as the national principal investigator for the APEX-AV IDE trial evaluating the AngioDynamics AlphaVac device. Her scholarly work includes multiple peer-reviewed and non–peer-reviewed publications that have advanced clinical understanding and techniques in venous intervention.
In addition to her venous expertise, Dr. Ranade has a strong clinical focus on arterial disease, including the treatment of claudication and critical limb ischemia. She is also highly experienced in the treatment of superficial vein disease, offering comprehensive, minimally invasive options to improve both clinical outcomes and quality of life for her patients.
Dr. Ranade has a deep commitment to improving care for women through minimally invasive therapies, with special research and clinical interests in DVT, PE, and arterial disease in women, as well as uterine fibroids, adenomyosis, and pelvic congestion syndrome. Her work seeks to address the unique presentations and treatment needs of female patients across a range of vascular and interventional conditions.
A proponent of patient-centered innovation, Dr. Ranade has championed procedural advancements such as radial artery access to improve safety, comfort, and recovery. Her approach integrates evidence-based care with a focus on individualized treatment.
Dr. Ranade’s clinical leadership, research contributions, and advocacy for women’s health continue to influence the evolving landscape of interventional radiology. -
Devin Rand-Giovannetti
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Devin Rand-Giovannetti is a licensed psychologist who specializes in the treatment of eating disorders and trauma. She received her BA with Honors from Wellesley College and her doctorate in Clinical Psychology from the University of Hawaiʻi at Mānoa. She completed her clinical internship at the Palo Alto Veterans Affairs Medical Center and her postdoctoral fellowship at Stanford University's School of Medicine. She provides psychotherapy and supervision from a cognitive-behavioral framework. Dr. Rand-Giovannetti currently serves patients through the PTSD and Eating Disorders Clinics at Stanford School of Medicine.
-
Thomas Rando, MD, PhD
Professor of Neurology and Neurological Sciences, Emeritus
Current Research and Scholarly InterestsOur laboratory studies the molecular mechanisms regulating stem cell function, the effects of aging on skeletal muscle and skeletal muscle stem cells, and the pathogenesis and experimental therapeutics for hereditary muscle diseases, specifically the muscular dystrophies.
-
Julia Raney
Clinical Assistant Professor, Pediatrics - Adolescent Medicine
Current Research and Scholarly InterestsAdolescents are dying from drug overdoses at unprecedented rates, largely secondary to fentanyl contamination in the drug supply. A Youth Overdose Prevention Toolkit for school-based health centers is needed to combat this trend. The toolkit should include key stakeholder-informed harm reduction approaches that focus on reducing injury or death from fentanyl and other opioids without exclusively recommending abstinence; this approach is evidence-based and critical to saving lives.
